Infosys Optimizes Clinical Trial Supply Chain with Cutting-Edge Cloud Solutions

Clinical trials are pivotal milestones within the journey of drug development, representing critical phases where the efficacy and safety of potential treatments are rigorously evaluated. Ensuring the smooth operation of these trials is paramount for pharmaceutical companies aiming to bring new therapies to market efficiently. However, despite the widespread use of SAP in commercial supply chains, leveraging it effectively for Clinical Trial Supply Management (CTSM) has remained a challenge for many.

Pharmaceutical companies navigating the landscape of clinical trials encounter multifaceted challenges. From the timely delivery of drugs to patient sites to cost optimization and regulatory compliance, the complexities are manifold. Meeting these demands necessitates not only operational excellence but also a robust IT infrastructure tailored to the unique requirements of clinical trial supply chains.

In response to these challenges, Infosys-Lodestone, presents a pioneering solution designed to address the intricate challenges inherent in clinical trial supply chains. This comprehensive CTSM solution, originally based on SAP but now available on the cloud, is poised to revolutionize how mid-market segments and contract research organizations (CROs) manage their clinical trial supply chains. By harnessing the power of cloud technology and integrating seamlessly with Ariba (now SAP Ariba), this solution offers enhanced performance and tighter collaboration between suppliers and customers.

The Infosys-Lodestone CTSM solution boasts an array of features meticulously crafted to streamline every aspect of clinical trial supply management. From clinical data management and demand planning to randomization and clinical packaging, each feature is designed to optimize processes and enhance efficiency throughout the supply chain. The solution also offers intuitive user interfaces and mobile-enabled transactions, empowering users with real-time access to critical information and facilitating faster decision-making.

Furthermore, the cloud-enabled features of the Infosys CTSM solution bring additional advantages, including seamless integration and collaboration, centralized systems for any time, anywhere access, and efficient data collection and management capabilities. By leveraging these features, pharmaceutical companies can enhance collaboration among stakeholders, streamline operations, and accelerate the pace of clinical trials.

The implementation of the Infosys Cloud-Based CTSM Solution promises a plethora of benefits for pharmaceutical companies. These include enhanced control over the entire project cycle, improved traceability of materials and kits throughout the supply chain, elevated compliance standards, and substantial cost savings. By streamlining clinical trial cycles and increasing efficiency, this solution has the potential to transform the landscape of clinical trial supply management, paving the way for faster and more cost-effective drug development processes.

About Infosys Limited

Infosys Limited, a leading global provider of next-generation digital services and consulting, has been at the forefront of driving digital transformation for clients across the globe. With a rich history spanning over four decades, Infosys has cultivated deep expertise in managing the complex systems of global enterprises. Operating in more than 56 countries, the company leverages its extensive experience to guide clients through their digital journeys, harnessing the power of cloud computing and artificial intelligence to drive innovation and efficiency.

Established in 1981, Infosys has evolved into a NYSE-listed powerhouse with over 322,000 employees worldwide. From its humble beginnings with a capital of US$250, the company has grown exponentially, boasting a staggering US$18.55 billion in total revenue (LTM Q3 FY24) and a market capitalization of US$76.29 billion. This remarkable growth trajectory underscores Infosys’ position as a key player in the global IT services landscape.

Throughout its 40-year journey, Infosys has played a pivotal role in shaping India’s emergence as a hub for software services talent. The company’s innovative Global Delivery Model revolutionized the industry, propelling Infosys to become the first Indian IT company listed on NASDAQ. Moreover, Infosys’ employee stock options program has empowered its workforce, creating opportunities for professional growth and financial success.

At the heart of Infosys’ mission is a commitment to excellence, sustainability, and inclusivity. The company is dedicated to fostering a culture of diversity and inclusion, where talent from all backgrounds can thrive in a supportive environment. Additionally, Infosys prioritizes environmental sustainability, striving to minimize its ecological footprint while maximizing social impact.

With a global footprint, a diverse workforce, and a steadfast commitment to innovation, Infosys continues to lead the way in driving digital transformation and delivering value to clients around the world.

Learn more about Infosys from their official website infosys.com.

Lodestone Holding AG

Headquartered in Zurich, Lodestone Holding AG is a prominent global consulting firm specializing in advising international companies on strategy, process optimization, and IT transformation. Established in 2005, Lodestone has swiftly risen to prominence, boasting a team of over 850 employees, including approximately 750 consultants, spread across 17 countries on five continents.

With a value-integration approach, Lodestone distinguishes itself by offering a unique blend of management and IT consulting services. The firm’s advisory expertise spans a wide range of industries, with a particular focus on life sciences, chemicals, financial services, investments, automotive, and consumer goods sectors.

In 2012, Infosys, a global leader in digital services and consulting, completed the acquisition of Lodestone Holding AG, marking a significant milestone in its expansion strategy. This strategic move bolstered Infosys’s management consulting capabilities and significantly expanded its footprint in continental Europe.

The acquisition of Lodestone brought on board more than 750 seasoned consultants and a portfolio of over 200 clients, primarily in industries such as manufacturing, automotive, and life sciences. Lodestone’s reputation for providing strategic guidance and business transformation solutions, particularly leveraging SAP technologies, further enhanced Infosys’s service offerings.

The collaboration between Infosys and Lodestone synergizes the strengths of both organizations, offering clients a formidable team equipped to drive transformational change and foster innovation-led growth. With a shared commitment to excellence and client-centricity, Infosys and Lodestone continue to deliver value-driven solutions to businesses worldwide, empowering them to navigate the complexities of the digital age with confidence.

Engr. Dex Marco Tiu Guibelondo, B.Sc. Pharm, R.Ph., B.Sc. CpE

Editor-in-Chief, PharmaFEATURES